Elderly Japanese are discovering the benefits of cannabis products
But the government remains hesitant to legalise marijuana
For most of her life Yoshimura Hiroko, an 81-year-old woman in Hadano near Tokyo, had never given a thought to cannabis. But when she started suffering pain and paralysis caused by multiple sclerosis three years ago, Kazuyoshi, her 51-year-old son, stumbled upon cannabidiol (cbd), a non-psychoactive cannabis compound. He started dropping a dose of cbd oil under her tongue each day; a month later the pain had faded.
Ms Yoshimura belongs to a growing club of elderly Japanese who have discovered cbd. Marijuana remains illegal in Japan, including for medical use. But a global trend towards its liberalisation has reduced the stigma associated with cbd products, which are legal. As a result, the local market is expected to grow to some $800m by 2024, up from a mere $59m in 2019. That suggests faster growth even than the global market, which could reach $47bn over the next six years, from $4.9bn in 2021.
Already have an account? Log in
Start your one-month free trial today
Discover insightful, in-depth analysis with a one-month free trial. Cancel at any time
View subscription options- Distinctive global analysis with more than 100 articles a week on The Economist app and economist.com
- An immersive world with podcasts and digital newsletters
- Intelligent debate with a global community in subscriber-only digital events
More from Asia
What is the legacy of BTS, the world’s biggest boyband?
As they announce a break, they leave behind contradictions
Indonesia’s campaign against Islamists is a ploy to silence critics
By defining radicalism broadly, it can demonise its opponents
What a giant stingray says about the Mekong
The discovery of the world’s biggest freshwater fish spells hope for the struggling river